Document:

aspn-ex102_298.htm

 

 

Exhibit 10.2

 

Amended and Restated 

Supply Agreement

 

 

 

 

between

 

 

BASF Polyurethanes GmbH

 

 

and

 

 

Aspen Aerogels, Inc.

Portions of this Exhibit, indicated by the mark “[***],” were omitted and have been filed separately with the Securities and Exchange Commission pursuant to the Registrant’s application requesting confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

Page 1 of 28

 

Amended and Restated 

Supply Agreement (the “Agreement”)

 

Between

 

BASF Polyurethanes GmbH

 Elastogranstraße 60, 49443 Lemförde, Germany

-hereinafter along with its Affiliates referred to as “BASF”-

 

and

 

Aspen Aerogels, Inc.

30 Forbes Road, Building B, Northborough, MA 01532, United States of America

-hereinafter along with its Affiliates  referred to as “ASPEN”-

 

BASF and ASPEN are hereinafter individually referred to as “Party” and collectively as “Parties”.

 

Portions of this Exhibit, indicated by the mark “[***],” were omitted and have been filed separately with the Securities and Exchange Commission pursuant to the Registrant’s application requesting confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

Page 2 of 28

 

Preamble

Whereas, based on the Memorandum of Understanding dated July 31, 2015 by and between the Parties, the Parties wish to expand the long-term global market for Spaceloft A2 taking into account an increasing demand for Spaceloft A2 from BASF, and

Whereas, ASPEN wishes to supply and deliver and BASF wishes to purchase and receive Spaceloft A2 at mutually agreed terms and conditions, and 

Whereas, ASPEN has commenced investment in (i) a capacity expansion program to increase production capacity of Spaceloft A2 and other aerogel products in its East Providence facility and in a second manufacturing plant, (ii) process optimization projects to reduce the cost of Spaceloft A2 and other aerogel products, and (iii) research, development and related activities in furtherance of the general goals of the JDA (“ASPEN Investment”), and

Whereas BASF is willing to support ASPEN Investment by entering into this Agreement together with the commitment to render a pre-payment for certain volumes of Spaceloft A2, and

Whereas, it is the common understanding of the Parties that the terms under which Spaceloft A2 will be sold and delivered by ASPEN shall also be applicable to the purchase and receipt of Spaceloft A2 by BASF and,  

Whereas, the Parties wish to achieve and maintain competitiveness by innovation and productivity improvements in cooperation with each other as set forth herein, 

Whereas, the Parties have previously entered into a supply agreement dated June 21, 2016 and hereby desire to modify said supply agreement as amended and restated in this Amended and Restated Agreement and

Now, therefore, the Parties hereto agree as follows: 

Portions of this Exhibit, indicated by the mark “[***],” were omitted and have been filed separately with the Securities and Exchange Commission pursuant to the Registrant’s application requesting confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

Page 3 of 28

 

Definitions

 

	
“Affiliate”
	
shall mean any entity that directly or indirectly controls, are controlled by, or are under common control with a Party;

	
“ASPEN”
	
shall mean ASPEN and any entity that is directly or indirectly controlled by ASPEN;

	
“ASPEN Investment”
	
shall have the meaning as defined in the Preamble; 

	
"BASF"
	
shall mean BASF Polyurethanes GmbH, Elastogranstraße 60, 49443 Lemförde, Germany, and any entity that is directly or indirectly controlled by, or under common control of BASF SE, Ludwigshafen/Rhine, Germany;

	
“BASF Markets”
	
shall have the meaning as defined in §1 and Annex 1 hereto;

	
“Effective Date”
	
shall mean the latest date set forth in the signature block below;

	
“EP20”
	
shall mean the set of activities contemplated, as of the Effective Date, by ASPEN to expand the manufacturing capacity of its East Providence, Rhode Island, United States of America plant by about twenty percent;

	
“JDA”
	
shall mean a framework joint development agreement to be entered into contemporaneously with this Agreement by ASPEN and BASF focusing on the joint development of new products, technology, intellectual property or know how;

	
“MoU”
	
shall mean the Memorandum of Understanding signed by ASPEN and BASF SE on July 31st, 2015;

	
“Optimization Projects”
	
shall have the meaning as defined in §12 below;

	
“Phase-Out Volume”
	
shall have the meaning as defined in §11 below;

	
“Plant Two”
	
shall mean the first production line in a production facility, to be constructed by ASPEN in Statesboro, Georgia, United States of America as a capacity expansion for manufacturing aerogel products including Products;

	
“Pre-Marketing Phase”
	
shall mean the period from [***] until [***];

Portions of this Exhibit, indicated by the mark “[***],” were omitted and have been filed separately with the Securities and Exchange Commission pursuant to the Registrant’s application requesting confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

Page 4 of 28

 

	
“Pre-Payment”
	
shall mean an amount of up to twenty two million U.S. Dollars ($22,000,000) to be paid by BASF on its sole discretion to ASPEN in accordance with §5 in multiple tranches; 

	
“Pre-Payment Tranche”
	
shall mean an amount agreed by the Parties to be paid by BASF to ASPEN on or before a specified date as a component of Pre-Payment with an associated Target Date and, if applicable, a revised Total Volume Range in accordance with §5 and as set forth in Annex 4; 

	
“Pre-Payment Balance”
	
shall mean the remaining portion of the Pre-Payment which has not been previously applied against amounts invoiced for Product purchased by BASF hereunder, or otherwise repaid by ASPEN.

	
“Price”
	
shall mean the price for the Products to be paid by BASF to ASPEN calculated as set forth in the Side Agreement and further defined in §4 hereto, as amended pursuant to the Section 1.4 of this Agreement to add Successor Products;

	
“Product” or “Products”
	
shall mean individually or collectively Spaceloft A2 and, if added under Section 1.4, Successor Products; 

	
“Recommended Measures”
	
shall mean non-binding recommendations by BASF to ASPEN for certain process optimization measures in accordance with §12 below;

	
“Safety Stock”
	
shall have the meaning as defined in §3;

	
“Security Interest”
	
shall mean collateral provided by ASPEN in favour of BASF SE to secure settlement of the Pre-Payment in accordance with §5 below and Annex 4 hereto;

	
“Side Agreement”
	
shall mean the side agreement between ASPEN and BASF dated June 21, 2016 and as amended and restated as of______, setting out the manner of calculation of the Price of Products sold hereunder.

	
“Spaceloft A2”
	
shall mean [***] with properties complying with Specifications and marketed as of the Effective Date as Spaceloft® A2;

	
“Specifications”
	
shall mean the specifications for the Products as further defined in §1 and Annex 1 hereto;

Portions of this Exhibit, indicated by the mark “[***],” were omitted and have been filed separately with the Securities and Exchange Commission pursuant to the Registrant’s application requesting confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

Page 5 of 28

 

	
“[***] Cost” 
	
shall mean [***], as further described in the Side Agreement.

	
“Successor Products”
	
shall mean any improvements, modifications or enhancements to Spaceloft A2 or the fabrication of panels or insulation boards  incorporating Spaceloft A2, as agreed to by both Parties from time to time pursuant to §1.4 and §1.5;

	
“Target Date”
	
shall mean a date agreed by the Parties with respect to each Pre-Payment Tranche in accordance with §5; 

	
“Target Volume”
	
shall mean the volume of Product to be sold and delivered by ASPEN and purchased and received by BASF in each calendar year as further defined in §2 below;

	
“Term”
	
shall mean the term of this Agreement in accordance with §11;

	
 “Total Volume Range”
	
shall mean the total annual volume range of Products in accordance with Annex 2 hereto;

	
“Transaction”
	
shall mean the transfer of all or substantially all of the assets of ASPEN directly related to the performance under this Agreement or the acquisition of over 50% (fifty percent) of the voting capital stock of ASPEN, in each case, to a third party who does not already own in excess of 5% (five percent) of the voting capital stock of ASPEN on the date of this Agreement. 

 

	
 
	
§1
	
Products

1.1ASPEN agrees to sell and deliver exclusively to BASF and BASF agrees to purchase and receive Products from ASPEN on the terms and conditions of this Agreement for resale to third parties or for incorporation into value added products and systems for sale to customers making use of the Products within the BASF Markets identified in Annex 1. BASF will not sell or otherwise supply Product to third parties who BASF knows, or reasonably should know, intend to use the Products in any markets other than the BASF Markets. For the sake of clarity, BASF acknowledges that nothing in this Agreement restricts ASPEN’s ability to sell its products other than Products to any third party or within any market anywhere in the world.

1.2In accordance with the Commission Regulation (EU No 1217/2010 of 14 December 2010 on the application of Article 101 (3) of the Treaty on the Functioning of the European Union to certain categories of research and development agreements, the Parties agree that the exclusivity of the supply of each of the respective Products from ASPEN to BASF as well as the restriction to the 

Portions of this Exhibit, indicated by the mark “[***],” were omitted and have been filed separately with the Securities and Exchange Commission pursuant to the Registrant’s application requesting confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

Page 6 of 28

 

BASF Markets with regard to sales by BASF to customers according to Article 1.1 will end [***] after the date of the first day the respective Product is being placed on the relevant market. Thereafter, exclusivity of the supply of each of the respective Products from ASPEN to BASF and the restriction to BASF Markets with regard to sales by BASF to customers may continue for a further period of [***] provided however that the joint market share of the Parties on the relevant market for the respective Product will be below [***]% during these [***]. If the relevant joint market share of the Parties is initially (i.e. at the end of the [***] period) not more than [***]% but subsequently rises above that level without exceeding [***]%, the provisions set forth in § 1.1 may continue to apply for a period of [***] consecutive calendar years following the year in which the [***]% market share threshold was first exceeded and shall thereafter cease to apply. If the relevant joint market shares of the Parties are initially not more than [***]% but subsequently rises above [***]%, the provisions set forth in §1.1 may continue to apply for [***] calendar year following the year in which the level of [***]% was first exceeded. The time frames set forth in this § 1.2 third sentence and § 1.2 fourth sentence may not be combined so as to exceed a period of [***] calendar years. Nothing in this subsection 1.2 shall be construed to extend the Term of this Agreement, unless such Term is expressly extended or renewed by both Parties in writing.

1.3The Products to be delivered shall be in accordance with the Specifications set forth in Annex 1 as of the date of delivery. The Specifications may be modified only upon the mutual written consent of both Parties.

1.4ASPEN shall inform BASF at least [***], or such shorter period as may be agreed by both Parties in writing, in advance of any changes that recognizably affect the quality of a Product as set forth in the Specifications. In particular, ASPEN shall inform BASF of changes to processes involving the introduction of new technologies, changes to raw materials and transfer of production to another location. Products that are affected by such changes may only be shipped after ASPEN has obtained the written consent of BASF. 

1.5Through the Term, ASPEN may develop Successor Products that would be supplied to BASF subject to the Parties reaching agreement as to revised specifications, pricing, volumes, and related terms.

1.6In case (i) BASF is not able to profitably meet the requirements of its customers or (ii) alternative product characteristics or specifications are required for BASF to meet legal requirements, in each case, with respect to Products, then BASF will immediately inform ASPEN thereof and provide ASPEN with a description of the specifications and characteristics of new products necessary to meet the requirements of BASF’s customers. ASPEN will initiate commercially reasonable development efforts to improve, modify or enhance Spaceloft A2, but only 

Portions of this Exhibit, indicated by the mark “[***],” were omitted and have been filed separately with the Securities and Exchange Commission pursuant to the Registrant’s application requesting confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

Page 7 of 28

 

to the extent that the efforts could be reasonably expected to achieve the desired specifications and characteristics of such enhanced products within a period of [***]. If successfully developed, and on agreement of the Parties as to revised specifications, pricing, volumes, and related terms for such enhanced products as provided in Section 1.5, such enhanced products will be deemed Successor Products. If ASPEN cannot develop such enhanced products within a period of [***], the Parties will consider development of such enhanced products for inclusion as a project under the JDA.

 

	
 
	
§2
	
Volumes and Forecasting

2.1During the Term, ASPEN will sell and deliver to BASF volumes of Product within the Total Volume Range for use in the BASF Markets, pursuant to §2.2 and §2.3. 

2.2During the Pre-Marketing Phase, BASF may elect to purchase Products in its sole discretion. BASF shall provide purchase orders for Product for delivery within calendar year [***]. The Parties will within [***] of ASPEN’s receipt of each order develop a mutually agreeable delivery schedule for delivery of such Product consistent with ASPEN’s lead times then in effect. 

2.3On or before [***] and each [***] thereafter, the Target Volume of Product to be purchased by BASF for the following calendar year, which shall be within the applicable Total Volume Range defined in Annex 2, shall be defined and ordered by BASF from ASPEN. The Parties will, within [***] of BASF’s order, develop a mutually agreeable delivery schedule for delivery of Product aggregating to the Target Volume in the following calendar year consistent with ASPEN lead times. The purchase and sale of the Target Volume thus ordered for each calendar year shall be binding upon the Parties. BASF orders for Product in volumes in excess of the Target Volume for each calendar year shall be binding on ASPEN only on Aspen’s express written acceptance of such orders. 

 

	
 
	
§3
	
Safety Stock

3.1ASPEN will build a Safety Stock of Product on or before [***] equivalent to [***] of the agreed Target Volume (see example in Annex 3) applicable to calendar year [***]. Such Safety Stock will be adjusted on or before [***] of each successive calendar year to [***] of the applicable Target Volume for such calendar year. At BASF’s direction, Safety Stock may be utilized to meet Target Volume in the event of a Force Majeure as defined in Section 7. 

3.2In addition, BASF will be entitled to direct ASPEN to sell and deliver Safety Stock to BASF once in any calendar year in the event that BASF’s requirements for Product exceed Target Volume 

Portions of this Exhibit, indicated by the mark “[***],” were omitted and have been filed separately with the Securities and Exchange Commission pursuant to the Registrant’s application requesting confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

Page 8 of 28

 

and ASPEN is unable to meet BASF’s additional requirements. After any delivery and sale of Products from Safety Stock to BASF, ASPEN will take commercially reasonable efforts to replenish Safety Stock within a six month period. ASPEN shall use commercially reasonable efforts to rotate Safety Stock to reduce aging of such Safety Stock.

 

	
 
	
§4
	
Prices and Conditions

4.1The Price for Product sold hereunder shall be calculated as set forth in the Side Agreement. The terms of this Agreement and the Side Agreement shall be the exclusive terms and conditions with respect to purchase and supply of Products under this Agreement and take precedence over any additional or different terms and conditions provided by either Party, to which notice of objection by the other Party is hereby given.  Neither the commencement of performance, delivery nor receipt of products or payment shall be deemed an acceptance of any additional or different terms and conditions.  None of the terms and conditions contained herein may be added to, modified, superseded or otherwise altered except in writing by duly authorized representatives of the parties.

4.2All Prices are in United States dollars. Prices are exclusive of all charges or levies of any nature, including all applicable federal, state, provincial, municipal or other governmental excise, sales, use, value added, occupational, import duties, or similar taxes or tariffs now in force or enacted in the future (collectively, the “Additional Charges”) and, therefore, are subject to an increase in an amount equal to any such Additional Charges that ASPEN may be required to collect or pay upon sale or delivery of Products purchased.  A certificate of exemption or similar document in appropriate form for the jurisdiction of BASF’s place of business and any jurisdiction to which Products are to be directly shipped hereunder is required in order to exempt the sale from sales or use tax liability.  BASF shall obtain and furnish evidence of such exemption at the time of placement of order.  BASF agrees to indemnify and hold harmless ASPEN and its successors and assigns from and against any liability for tax in connection with the sale or use, as well as the collection or withholding thereof, including penalties and interest. ASPEN will provide a certificate of origin with any shipment of Products. ASPEN and BASF will work together to ensure (including providing any reasonable declaration) the transactions pursuant to this Agreement can benefit from the anticipated Transatlantic Trade and Investment Partnership. 

4.3On request of BASF, ASPEN’s books and records as they relate to annual Price calculations may be audited by an independent third party auditor without a prior business relationship with either BASF or ASPEN. Such audit will be to examine whether Price has been calculated by ASPEN in accordance with the provisions of this Agreement in all material respects. ASPEN will make available or provide access to all relevant documents to the third party auditor. The 

Portions of this Exhibit, indicated by the mark “[***],” were omitted and have been filed separately with the Securities and Exchange Commission pursuant to the Registrant’s application requesting confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

Page 9 of 28

 

independent auditor will provide a summary report to BASF and ASPEN on whether ASPEN’s Price calculations are consistent in all material respects with the provisions of this Agreement. The third party auditor will keep all other information of ASPEN strictly confidential and will not disclose such information to BASF or any other third party. ASPEN shall bear the costs of the third party auditor in the event ASPEN’s Price calculations are not consistent in all material respects with the provisions of this Agreement. Otherwise BASF shall bear such audit costs. 

4.4All orders must be placed in writing and verbal orders shall be confirmed in writing.  All orders must include requested delivery dates, quantities, shipment destination and complete description of Products being ordered.  After receipt of an order, ASPEN will confirm its acceptance in writing and may also inform BASF of an estimated ship date simultaneously or at a later date. Orders accepted or acknowledged by ASPEN cannot be cancelled without the prior written consent of ASPEN.  No order can be cancelled after the order is shipped. 

4.5 All Products will be shipped [***] (Incoterms 2010) from ASPEN’s applicable facility in the U.S. to [***] (“Delivery Point”) and further to [***] (“Destination Point” which, if not specified in the relevant order, will be [***]), unless agreed otherwise in writing.  All shipping, handling, transportation, and insurance costs incurred following the release of Product from ASPEN’s applicable facility in the U.S. to the Destination Point shall, to the extent paid by ASPEN, be either included as a separate item in the invoice for Products, or separately invoiced and payable by BASF. In no event shall ASPEN be liable for any delay in delivery caused between Delivery Point and Destination Point, nor shall the carrier selected by ASPEN for the transport from Delivery Point to Destination Point be deemed an agent of ASPEN.  ASPEN may make partial shipments against an order in its sole discretion. Each such shipment shall constitute a separate sale, and BASF shall pay for the units shipped whether such shipment is in whole or partial fulfilment of an order. Title to Products shall pass to BASF upon delivery of Products at the Delivery Point. 

4.6  BASF shall examine the Products as soon as possible after their arrival at the BASF’s facility, and in any event not more than [***] following the Product’s arrival at BASF’s designated facility.  BASF shall notify ASPEN in writing (i) with respect to missing Products, immediately upon receipt by reference to the accompanying bill of lading, and (ii) with respect to Products that do not conform to applicable Specifications or are damaged in transit due to inadequate packaging, within [***].  The Products will be deemed to conform to the applicable Specifications despite minor discrepancies that are usual in the trade, and BASF will not be entitled to abatement of the Price for such minor discrepancies.  Where the Products are materially non-conforming, the remedies provided in the limited warranty set forth herein shall serve as BASF’s exclusive remedy.  

	
 
	
§5
	
Pre-Payment and Payment Terms

Portions of this Exhibit, indicated by the mark “[***],” were omitted and have been filed separately with the Securities and Exchange Commission pursuant to the Registrant’s application requesting confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

Page 10 of 28

 

5.1In order to support ASPEN Investment, BASF (or its Affiliate) will provide the Pre-Payment to ASPEN in accordance with Annex 4. The Parties agree that a specified portion of the Pre-Payment will be credited as provided in Annex 4 by ASPEN against payment due on sales and deliveries of Products by ASPEN to BASF after January 1, 2019.

5.2 If by the Target Date associated with a specific Pre-Payment Tranche, credits associated with the sale and delivery of Product by ASPEN to BASF have not fully covered the value of the Pre-Payment Tranche, BASF shall be entitled to request from ASPEN the repayment of the remainder of the associated Pre-Payment Balance to BASF as specified in Annex 4 (“BASF Request”). The BASF Request may be executed at any time at or after the applicable Target Date with six weeks prior written notice. If ASPEN does not repay remaining Pre-Payment Balance by the due date per the BASF Request, BASF may apply a finance charge at the annual rate of [***], starting from the due date per the BASF Request. ASPEN shall be liable for any costs or expenses incurred by BASF in collecting any late payment, including, but not limited to, administrative and personnel costs, collection agency fees and expenses, court costs, and attorney’s fees and expenses.

5.3As collateral for the Pre-Payment, ASPEN will provide BASF with a Security Interest in ASPEN’s assets in accordance with Annex 4.

5.4ASPEN shall invoice all orders for Product on shipment. BASF shall settle all invoiced amounts due to ASPEN within [***] of the date of the corresponding invoice.  Unless not otherwise instructed by BASF, ASPEN will apply an amount (if available) of the Pre-Payment Balance against payment of up to twenty five and three tenths percent (25.3%) of the invoiced Price of Product. BASF shall remit the remainder in cash in United States dollars by wire transfer. Cash payments not received within the prescribed time shall be assessed a finance charge at the annual rate of [***], starting from the invoice date.  BASF shall be liable for any costs or expenses incurred by ASPEN in collecting any late payment, including, but not limited to, administrative and personnel costs, collection agency fees and expenses, court costs, and attorney’s fees and expenses. Any credits applied pursuant to this Section 5.3 shall be deducted from the remaining Pre-Payment Balance associated with the earliest available Pre-Payment Tranche(s). 

5.5To the extent a BASF Affiliate orders and purchases Products pursuant to this Agreement, ASPEN shall send the respective invoice(s) directly to such Affiliate and such BASF Affiliate shall be responsible for payment of such invoices, subject to the partial credit against Pre-Payment Balance as described in § 5.1. 

5.6Any Pre-Payment hereunder shall not be construed as compensation for JDA activities.  Any work contemplated in connection with these Pre-Payments shall not be construed to be any project under the JDA or within any Project Charters of the JDA. Mutually agreed Project Charters under the JDA shall exclusively govern the scope and terms of activities pursuant to the JDA.

Portions of this Exhibit, indicated by the mark “[***],” were omitted and have been filed separately with the Securities and Exchange Commission pursuant to the Registrant’s application requesting confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

Page 11 of 28

 

 

	
 
	
§6
	
Warranty 

6.1ASPEN warrants to BASF that the Products supplied pursuant to this Agreement are free from defects in workmanship and materials for a period of one (1) year from the date of shipment to BASF.  This limited warranty does not apply to fitness for any particular purpose or for use in any application.  Since BASF may obtain devices which have the capability of testing whether Product meets the specifications, no claim of any kind with respect to the conformance of Product to the specifications, whether or not based on negligence, warranty, strict liability or any other theory of law, will be greater than the Price of the quantity of nonconforming Product in respect to which such claim is made.  The foregoing constitutes BASF's exclusive remedy and ASPEN's sole obligation with respect to any such claim. This limited warranty does not extend to any Product that has been damaged or rendered defective (a) as a result of accident, misuse, abuse, negligence, installation, act of God, disaster, or other external cause, (b) by the use of parts not manufactured or sold by ASPEN, or (c) by modification or service by anyone other than (i) ASPEN or (ii) anyone authorized by ASPEN.  ASPEN is not responsible for damage that occurs as a result of (i) BASF’s failure to follow the instructions that accompany the Products or otherwise provided by ASPEN or (ii) by operation outside the usage parameters specified by ASPEN.  No credit shall be allowed for repair work performed by BASF or unauthorized parties.  BASF shall notify ASPEN of any non-conformance during the warranty period, obtain from ASPEN a return material authorization (“RMA”) for the non-conforming Products, and return the non-conforming Products to ASPEN, freight prepaid, within [***] of receipt of the RMA, with a statement describing in reasonable specificity the non-conformity for which the Products are returned.  ASPEN’s exclusive obligation with respect to the non-conforming Products shall be, at ASPEN’s option, to repair or replace any Product determined to be defective.  Products that are repaired or replaced hereunder shall be warranted as set forth above for the remainder of the original warranty period or for [***] after the replacement Products are shipped to BASF, whichever is later.

6.2NOTWITHSTANDING ANYTHING HEREIN TO THE CONTRARY OR ANY APPLICABLE LAW OR REGULATION, THE FOREGOING IS BASF’S SOLE AND EXCLUSIVE REMEDY FOR BREACH OF WARRANTY BY ASPEN WITH RESPECT TO THE PRODUCTS.  ASPEN MAKES NO OTHER WARRANTIES, EXPRESS OR IMPLIED, INCLUDING ANY IMPLIED WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, AND ALL OTHER WARRANTIES ARISING FROM COURSE OF DEALING OR USAGE ARE HEREBY EXCLUDED.  IMPLIED WARRANTIES THAT MAY BE IMPOSED BY LAW AND CANNOT BE DISCLAIMED ARE LIMITED IN DURATION TO THE LIMITED WARRANTY PERIOD SET FORTH HEREIN.  BASF PURCHASES AND ACCEPTS THE PRODUCTS SOLELY ON THE BASIS OF THE LIMITED WARRANTY EXPRESSED HEREIN.  UNDER NO CIRCUMSTANCES SHALL ASPEN BE LIABLE BY VIRTUE OF THIS LIMITED WARRANTY OR OTHERWISE FOR ANY SPECIAL, 

Portions of this Exhibit, indicated by the mark “[***],” were omitted and have been filed separately with the Securities and Exchange Commission pursuant to the Registrant’s application requesting confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

Page 12 of 28

 

INDIRECT, SECONDARY, INCIDENTAL OR CONSEQUENTIAL DAMAGES (INCLUDING BUT NOT LIMITED TO LOSS OF PRODUCTION TIME) TO ANY PERSON OR PROPERTY ARISING OUT OF THE USE OR INABILITY TO USE THE PRODUCTS.  SOME JURISDICTIONS DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL DAMAGES, SO THE ABOVE LIMITATION OR EXCLUSION MAY NOT APPLY.   THE LIABILITY OF ASPEN HEREUNDER FOR ALL CLAIMS EXCEPT FOR CLAIMS ACCORDING TO § 5.2 RELATED TO REPAYMENT OF REMAINING PRE_PAYMENT BALANCE,  SHALL NOT EXCEED THE SUM OF BASF’S PAYMENTS FOR THE PRODUCTS THAT ARE THE SUBJECT OF DISPUTE. EXCEPT IN CONNECTION WITH AN AUTHORIZED SALE, FOR ANY PRODUCTS THAT ARE DIVERTED FROM ASPEN’S INTENDED COUNTRY OF DESTINATION TO ANOTHER COUNTRY OR JURISDICTION, THE WARRANTY IS HEREBY VOIDED. NOTWITHSTANDING ANY ALLOWED MARKETS OR END-APPLICATIONS AS DESCRIBED IN ANNEX 1, BASF SHALL BE RESPONSIBLE FOR ENSURING FITNESS FOR USE OF PRODUCTS IN ALLOWED MARKETS OR END-APPLICATIONS INCLUDING CONDUCTING ANY APPLICABLE TESTS. ACCORDINGLY, ASPEN HEREBY DISCLAIMS ANY LIABILITY, WARRANTY OR OTHERWISE WITH RESPECT THERETO. 

 

	
 
	
§7
	
Force Majeure

7.1Any and all events and circumstances beyond the reasonable control of the Parties including, but not limited to acts of God, fires, explosions, floods, earthquakes, civil commotions, riots, declared and undeclared wars, labor disputes, strikes, lock-outs, boycotts, picketing, other industrial disturbances, unavoidable break-downs and acts of authorities, military police actions, blockades, embargoes, insurrections, delays or curtailment of sources of supply of materials used in the manufacture of the Products, performance failure or delays of any person other than the Party, all interruptions of business and casualties (collectively, “Force Majeure”) release the Party hereto from its respective obligations under or pursuant to this Agreement - in so far as the circumstances prevent the deliveries of Product by ASPEN or the takings or further processing of Product by BASF or BASF’s Affiliates - for the duration of such contingencies and to the extent of the effects resulting therefrom.

7.2If a Force Majeure event occurs, the Party affected shall inform the other Party as soon as practical indicating the expected duration and extent of such contingency. Moreover, the affected Party shall promptly take commercially reasonable efforts to settle such contingencies so that the performance of the obligations under this Agreement can be resumed as soon as possible.

	
 
	
§8
	
Good Faith

Portions of this Exhibit, indicated by the mark “[***],” were omitted and have been filed separately with the Securities and Exchange Commission pursuant to the Registrant’s application requesting confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

Page 13 of 28

 

8.1Both Parties recognise that they cannot anticipate all future technical and economic developments that could affect the rights, obligations and commitments contemplated herein. Therefore, ASPEN and BASF agree to cooperate and work with one another in good faith during the Term, taking into account any and all unanticipated developments and occurrences to minimise any undesired impact on the intent of this Agreement. If during the Term of this Agreement, there shall occur any unanticipated hardship affecting one of the Parties, whether economic or otherwise, [***], the Parties shall work with one another in good faith so as to minimise, to the extent possible, any adverse impact on the affected Party.

	
 
	
§9
	
Assignment

9.1It is the common understanding of the Parties that the terms of the Agreement under which Product will be sold and delivered by ASPEN to BASF shall also be applicable to the sale and delivery of Product to BASF’s Affiliates and also to the sale and delivery of Product from ASPEN’s Affiliates to BASF and BASF Affiliates. Therefore, BASF Affiliates shall be entitled to order Product from ASPEN or ASPEN’s Affiliates in their own name and on their own account at the terms laid down in this Agreement. In case BASF and BASF Affiliates have placed orders pursuant to the terms and conditions of this Agreement, the Target Volumes set out in Section 2 shall be fulfilled to the extent of the quantity invoiced to BASF and the respective BASF Affiliates.

9.2In addition, each of the Parties is entitled to assign rights and obligations under this Contract, in whole or in part, to one of its Affiliates.

9.3In addition, no consent shall be required to assign this Agreement as a part of a Transaction, provided that any Transaction will be subject to Section 11.6.

	
 
	
§10
	
Confidentiality

10.1BASF and ASPEN agree that all non-public and/or proprietary information or samples (“Confidential Information”) received or learned from the other Party,  in connection with negotiations, performance and compliance of this Agreement will be treated as strictly confidential and each Party (i) shall not disclose Confidential Information of the other Party to third parties, and (ii) shall not use Confidential Information of the other Party for any purpose other than as expressly permitted in this Agreement unless otherwise agreed by the Parties in writing, in each case during the Term and for a period of ten (10) years after the termination or expiration of this Agreement. However, if a Party is required to disclose any Confidential Information of the other Party by a governmental authority pursuant to applicable laws or regulations, including, without limitation, the U.S. Securities and Exchange Commission, the Party required to make disclosure will immediately (if and to the extent allowed by law) (i) inform  the other Party of such required disclosure, and (ii) may make such disclosure to the extent required by law, and, to the extent requested by the other 

Portions of this Exhibit, indicated by the mark “[***],” were omitted and have been filed separately with the Securities and Exchange Commission pursuant to the Registrant’s application requesting confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

Page 14 of 28

 

Party, shall use commercially reasonable efforts to seek confidential treatment of such Confidential Information if permitted by such laws or regulations under such circumstances. The provisions of this Section 10 shall not apply to (i) disclosures by each Party to its Affiliates and their respective personnel, or (ii) disclosure to a potential purchaser or financing source of each Party, including such purchaser's attorneys and consultants, provided that such persons receiving Confidential Information first agree to maintain the confidentiality of Confidential Information provided under this Agreement, subject to the terms and restrictions contained herein. Each Party is responsible for compliance with this Section 10 by any such persons to whom such Party discloses the other Party’s Confidential Information. 

10.2Confidential Information excludes any information which a receiving Party can demonstrate by written evidence: (a) to be in the possession of the receiving Party at the time of disclosure without any restrictions; (b) already available or becomes available to the public through no fault of the receiving Party; (c) received by the receiving Party from a third party having a right to disclose it without restrictions; or (d) developed by the receiving Party without the knowledge or reference to information disclosed pursuant to this Agreement or other agreements between the Parties. The Confidential Information disclosed pursuant to this Agreement shall not be construed to be within the foregoing exclusions merely because such items are embraced by more general publically known information or information in Receiving Party’s possession. Additionally, any combination of features shall not be construed within the foregoing exclusions, but only if combination itself and its principle of operation are within the foregoing exclusions.

 10.3BASF acknowledges and agrees that it will acquire no rights to use and/or disclose the Confidential Information of ASPEN by virtue of the utilization of such Confidential Information in the manufacture of Products sold to BASF hereunder.

 

	
 
	
§11
	
Term and Termination

11.1This Agreement becomes effective on the Effective Date and shall terminate on December 31st, 2027 (the “Term”). The Parties agree to meet and discuss the potential for a successor arrangement to the Agreement at least [***] prior to the end of the Term. 

11.2In the event the Agreement is not renewed beyond December 31, 2027, ASPEN shall sell and deliver and BASF shall be obliged to purchase and receive under the same terms and conditions as laid out in the Agreement, the following Phase-Out Volumes:

(a) During the first calendar year following the expiration of the Agreement, the Phase-Out Volume shall be equal to [***] of the quantities invoiced by ASPEN to BASF during the final calendar year of the Agreement.

Portions of this Exhibit, indicated by the mark “[***],” were omitted and have been filed separately with the Securities and Exchange Commission pursuant to the Registrant’s application requesting confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

Page 15 of 28

 

(b) During the second calendar year following the expiration of the Agreement, the Phase-Out Volume shall be equal to [***] of the quantities invoiced by ASPEN to BASF during the last final calendar year of the Agreement.

The terms and conditions of this Agreement shall continue to apply to purchases of Phase-Out Volumes

11.3If either Party defaults in any of its obligations under this Agreement and, if it is capable of remedy, such default has not been remedied within thirty (30) days after the non-defaulting Party gives written notice thereof, the non-defaulting Party may at its discretion terminate this Agreement by giving written notice should such default be continuing. 

11.4Notwithstanding any other provision of this Agreement, no return or other refund of the Pre-Payment Balance shall be due before the applicable Target Date, absent a showing of fraud or willful misconduct on the part of ASPEN. ASPEN will also grant BASF access to its financial data upon request.

11.5The following provisions will survive any expiration or termination of this Agreement: Sections 8, 10, 11, 12.3, 13, 14, 15 and 16.

11.6ASPEN shall provide BASF written notice at least [***] prior to a proposed Transaction (a “Transaction Notice”) identifying the proposed acquirer. BASF shall have the right to terminate this Agreement by written notice to ASPEN (the “Transaction Termination Notice”) on or prior to the date that is [***] after the date of the Transaction Notice if any of the following is the case:

(a) the proposed acquirer is a competitor of BASF;

(b) the proposed acquirer does not provide reasonable assurance to BASF that this Agreement will in the future be performed in accordance with its terms, specifically with its §5, or

(c) the proposed acquirer is for other material reasons (e.g. financial, political reasons) determined by BASF not to be a reasonably reputable supplier of the Products. 

A termination pursuant to a Transaction Termination Notice shall be effective on the date of the Transaction.

11.7Notwithstanding the foregoing, if specified in the Transaction Termination Notice, BASF may continue to purchase the remainder of its Target Volume for the remainder of the calendar year in which the Transaction Termination Notice is given and the subsequent calendar year, and the terms of this Agreement shall apply to all such sales.

Portions of this Exhibit, indicated by the mark “[***],” were omitted and have been filed separately with the Securities and Exchange Commission pursuant to the Registrant’s application requesting confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

Page 16 of 28

 

11.8Upon a termination of this Agreement pursuant to a Transaction Termination Notice, the remaining Pre-Payment Balance shall be due and payable to BASF within [***] of the date of the Transaction.

	
 
	
§12
	
Process Optimization

12.1 BASF and ASPEN agree to work together in good faith to identify optimization projects [***] (“Optimization Projects”) and [***] as set forth in the Side Agreement. ASPEN may from time to time submit Optimization Project proposals to BASF. BASF will assess such Optimization Project proposals in good faith to develop non-binding Recommended Measures, if any, to meet Optimization Project goals. In addition, BASF, in its sole discretion, may provide further assistance to ASPEN during implementation of Recommended Measures to help promote the likelihood of successful cost reductions. ASPEN, in its sole discretion, may elect to or not elect to implement Recommended Measures. BASF will not incur any liability with respect to ASPEN’s use of the Recommended Measures and related assistance. 

12.2If the cost of development of any Recommended Measures is expected to be significant, the Parties will, prior to the undertaking by BASF of any work related to such Recommended Measures, agree on a scope of work and any reimbursement of BASF to be paid by ASPEN, on a time and materials basis, for the work of BASF related to the Recommended Measures. If the implementation of any Recommended Measures and use thereof would infringe any patent owned or controlled by BASF, BASF shall inform ASPEN and the Parties shall reasonably negotiate and agree on the compensation, if any, due to BASF based on ASPEN’s practice of the patent as a part of the Recommended Measures.  ASPEN shall have a worldwide, nonexclusive right and license, including the right to grant sublicenses, to practice such patent to the extent required to implement the Recommended Measures. Should either Party believe that work related to the Recommended Measures is likely to lead to patentable developments, the Parties will refer such work to the joint steering committee established under the JDA, and undertake the work related to such Recommended Measures and implement such Recommended Measures only (if at all) as a Project executed under the JDA.

12.3 For such Recommended Measures as ASPEN does implement, ASPEN shall have a nonexclusive, worldwide, royalty free, perpetual right and license, including the right to grant sublicenses in connection with a license of rights in ASPEN’s process to which the Recommended Measures relate, to use any intellectual property rights of BASF included in such Recommended Measures in implementing such Recommended Measures in ASPEN’s processes. ASPEN shall continue to solely own all rights in its manufacturing and other processes, including as modified by any Recommended Measures.

Portions of this Exhibit, indicated by the mark “[***],” were omitted and have been filed separately with the Securities and Exchange Commission pursuant to the Registrant’s application requesting confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

Page 17 of 28

 

12.4 Except as provided in Section 12.2, BASF will not include in any Recommended Measures any patented technology or processes other than through a Project executed under the JDA.

 

	
 
	
§13
	
Other Terms and Conditions

13.1Any alterations or amendments to any provision of this Agreement, including amendments to the Annexes hereto, shall only be valid if made in writing by authorized representatives of the Parties.

13.2In the event that any of the provisions of this Agreement are invalid because they are inconsistent with the applicable law, this shall in no manner affect the validity of the other provisions of this Agreement. The Parties hereto shall be obliged to replace such invalid provisions by new provisions having similar economic effects.

13.3Neither BASF's nor ASPEN's general or other conditions that may accompany orders or acknowledgements are applicable to any orders for Products placed pursuant to this Agreement.

13.4Each Party represents and warrants that it has the authorizations required to enter into this Agreement and that entering into this Agreement is not inconsistent with any prior arrangements with or commitments to third parties.

13.5The terms and conditions contained herein, including the Annexes hereto, constitute the entire agreement between the Parties with respect to the subject matter of this Agreement and shall supersede all prior and contemporaneous negotiations, agreements, statements, communications either oral or written between the Parties hereto with respect to the subject matter hereof. Notwithstanding the foregoing, the Parties agree that confidentiality agreements between them remain in effect according to their terms with respect to obligations of confidentiality and non-use with respect to information exchanged thereunder, and rights of ownership in intellectual property established under the terms of a Joint Development Agreement dated March 1, 2010 between ASPEN and BASF Construction Chemicals GmbH remain in effect. A supply agreement entered into by and between ASPEN and BASF Construction Chemicals GmbH, Trostberg, Germany, an affiliate of BASF SE, Ludwigshafen, Germany, on February 17th, 2012, along with the amendments thereto, is hereby terminated in its entirety by mutual consent.

 

	
 
	
§14
	
Law and Jurisdiction

14.1This Agreement, including the law and jurisdiction clause and any amendment hereto shall be governed by, interpreted and enforced in accordance with the substantive laws of Switzerland 

Portions of this Exhibit, indicated by the mark “[***],” were omitted and have been filed separately with the Securities and Exchange Commission pursuant to the Registrant’s application requesting confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

Page 18 of 28

 

without regard to the principles of conflict of laws and excluding the United Nations Convention on Contracts for International Sale of Goods of 11 April 1980(CISG). Any dispute, controversy or claim, arising out of or in relation to this Agreement, including the validity, invalidity, breach or termination thereof, shall be resolved by binding arbitration in accordance with the Swiss Rules of International Arbitration of the Swiss Chambers of Commerce in force on the date when the Notice of Arbitration is submitted in accordance with these Rules. The number of arbitrators shall be one (1). The seat of arbitration shall be Basel, Switzerland. The arbitral proceedings shall be conducted in English. All information involved in the arbitration shall be kept confidential.  Notwithstanding the foregoing, the Parties recognize that a Party may suffer immediate, irreparable harm in certain circumstances, including a breach or threatened or anticipated breach of obligations under Section 10; accordingly, such Party is entitled, in addition to any other remedy available at law or in equity, to injunctive relief to specifically enforce the terms of this Agreement in a court of competent jurisdiction.

 

§ 15 Export Compliance

15.1The Parties shall comply with their respective codes of conduct, all applicable laws and regulations, including but not limited to export controls, embargoes, sanctions and similar laws, regulations and requirements. 

15.2BASF acknowledges that the Products are subject to regulation by United States government agencies, which regulate export or diversion of the Products, information about the Products, and derivatives of the Products to certain countries and certain persons (collectively, “U.S. Export Control Laws”).  BASF shall fully comply with all applicable laws and regulations, including trade control regulations in connection with its resale or use of Products. BASF will not export, sell, deliver or otherwise transfer any Products to any embargoed or sanctioned countries without necessary and appropriate licenses or approvals.

 

§ 16 Indemnification; Limitation of Liability

16.1ASPEN shall indemnify BASF, and its directors, officers, employees, agents and their successors, against any infringement claims brought by a third party based on such third party’s intellectual property only to the extent such claims relate to ASPEN’s manufacture of the Products, up to the amount of the Price paid for the Product. ASPEN shall not be liable for any claims related to the use of the Products in any application. ASPEN shall have no liability for any claim of infringement resulting from compliance by ASPEN with BASF’s designs, specifications or 

Portions of this Exhibit, indicated by the mark “[***],” were omitted and have been filed separately with the Securities and Exchange Commission pursuant to the Registrant’s application requesting confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

Page 19 of 28

 

instructions, or in the event of modification of the Products by BASF. In no event shall ASPEN have any liability for any infringement in excess of the purchase Price of the infringing Products.  

16.2 BASF shall indemnify and hold harmless ASPEN, and its directors, officers, employees, agents and their successors against third party claims resulting from BASF’s use of Products, whether alone or in combination with other products, including, but not limited to, infringement of intellectual property rights.

16.3ASPEN’s maximum liability for any losses and damages arising out of any cause whatsoever in connection with this Agreement shall in any event not exceed the sum of BASF’s payments for the products that are the subject of dispute. ASPEN shall provide to BASF a certificate evidencing its insurance coverage on BASF’s reasonable request. The aforesaid limitation of liability does not apply in cases of ASPEN’s willful misconduct or gross negligence. 

16.4OTHER THAN WITH RESPECT TO REPAYMENT OF THE PREPAYMENT BALANCE AS PROVIDED HEREUNDER, AND FOR INDEMNIFICATION CLAIMS UNDER THIS SECTION 16, NO PARTY SHALL BE LIABLE TO THE OTHER PARTY UNDER THIS AGREEMENT FOR ANY INCIDENTAL OR CONSEQUENTIAL DAMAGES, INCLUDING BUT NOT LIMITED TO LOST PROFITS, OR OTHER INDIRECT LOSS OR DAMAGE ARISING OUT OF THIS AGREEMENT AND/OR THE PERMITTED USE OF ANY INTELLECTUAL PROPERTY OR PROPRIETARY INFORMATION CREATED OR RECEIVED HEREUNDER, OR ARISING OUT OF NEGLIGENCE OR WILLFUL CONDUCT CAUSING PERSONAL INJURY OR TANGIBLE PROPERTY DAMAGE OF A THIRD PARTY OR ANY RESULTING OBLIGATION, WHETHER IN AN ACTION FOR OR ARISING OUT OF BREACH OF CONTRACT, TORT, OR ANY OTHER CAUSE OF ACTION AND WHETHER OR NOT SUCH DAMAGES ARE FORESEEABLE.

16.5Provisions.

(a)When a reference is made in this Agreement to an “Article,” “Section,” “Exhibit” or “Schedule,” such reference shall be to an Article or Section of, or an Exhibit or Schedule to, this Agreement unless otherwise indicated.

(b)The table of contents and headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement. 

(c)Whenever the words “include,” “includes,” or “including” are used in this Agreement, such words shall be deemed to be followed by the words “without limitation.”

Portions of this Exhibit, indicated by the mark “[***],” were omitted and have been filed separately with the Securities and Exchange Commission pursuant to the Registrant’s application requesting confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

Page 20 of 28

 

(d)The words “hereof,” “herein,” and “hereunder” and words of similar import when used in this Agreement refer to this Agreement as a whole and not to any particular provision of this Agreement unless otherwise expressly indicated in the accompanying text.

(e)The use of “or” is not intended to be exclusive unless otherwise expressly indicated in the accompanying text.

(f)The defined terms contained in this Agreement are applicable to the singular as well as the plural forms of such terms.  Reference to the masculine gender shall be deemed to also refer to the feminine gender and vice versa. 

(g)A reference to documents, instruments or agreements also refers to all addenda, exhibits or schedules thereto.

IN WITNESS WHEREOF, the parties have executed this Supply Agreement as of the dates set forth below.

 

 

ASPEN AEROGELS, INC.BASF POLYURETHANES GmbH

 

 

 

 

/s/ John F. Fairbanks                             [***]_               [***] 

Name: John F. Fairbanks  Name:[***]                 Name: [***]

Title: Chief Financial Officer  Title: [***]            Title: [***]

Date: February 16, 2018      Date: 02-16-2018                        Date: 02-16-2018

   

 

 

 

 

Portions of this Exhibit, indicated by the mark “[***],” were omitted and have been filed separately with the Securities and Exchange Commission pursuant to the Registrant’s application requesting confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

Page 21 of 28

 

List of Annexes:

 

Annex 1:BASF Markets and Specifications

Annex 2:Total Volume Range

Annex 3.Safety Stock

Annex 4:Pre-Payment and Security Interest

Portions of this Exhibit, indicated by the mark “[***],” were omitted and have been filed separately with the Securities and Exchange Commission pursuant to the Registrant’s application requesting confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

Page 22 of 28

 

Annex to the Agreement between BASF and ASPEN

	
 
	
Annex 1
	
–  BASF Markets and Specifications

 

BASF Markets

 

Market definitions are aligned to and based on categorization of markets set forth on [***] as of [***].  

 

BASF Markets will be limited strictly to those markets specifically identified as approved in the chart below.  Any additions or modifications to BASF Markets after the date hereof must be agreed to by both Parties in writing. 

 

	
1.
	
Construction

 

	
 
	
a.
	
Use in [***] is approved.

	
 
	
b.
	
Use in the following [***] is prohibited.

 

	
2.
	
Transportation

 

	
 
	
a.
	
Use in [***] is approved.

 

	
3.
	
Industrial

 

	
 
	
a.
	
Use in [***] is approved.

	
 
	
b.
	
Use in [***] is prohibited.

 

	
4.
	
Consumer

 

	
 
	
a.
	
Use in [***] is approved.

	
 
	
b.
	
Use in [***] is prohibited.

 

For purposes of clarity, any uses in [***] are allowed. Uses in [***] are prohibited.

 

The fact that a market or end-application is allowed in this Annex shall not be construed as ASPEN having determined that Products are fit for use in these markets or end-applications. BASF shall be solely responsible for ensuring fitness for use, including performing any additional tests, as necessary to market and sell the Products in these markets and end-applications in compliance with applicable regulations, industry standards and other product claims. 

Portions of this Exhibit, indicated by the mark “[***],” were omitted and have been filed separately with the Securities and Exchange Commission pursuant to the Registrant’s application requesting confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

Page 23 of 28

 

Specifications 

 

[***]

 

 

 

 

 

 

 

Portions of this Exhibit, indicated by the mark “[***],” were omitted and have been filed separately with the Securities and Exchange Commission pursuant to the Registrant’s application requesting confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

Page 24 of 28

 

 

	
 
	
Annex 2
	
- Quantities

 

Total Volume Range

Commencing [***], in an amount not to exceed [***] of Products in any calendar year during the term of the Agreement, subject to revision pursuant to amendment of Annex 4 with respect to any additional Pre-Payment Tranche(s).

Portions of this Exhibit, indicated by the mark “[***],” were omitted and have been filed separately with the Securities and Exchange Commission pursuant to the Registrant’s application requesting confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

Page 25 of 28

 

 

	
 
	
Annex 3
	
- Safety Stock

 

Safety Stock Example

Calendar Year:   [***]

Total Volume Range (up to):  [***]

Target Volume:  [***]

Safety Stock Factor:    [***]

[***] Safety Stock    [***]

 

 

 

  

 

 

 

 

 

Portions of this Exhibit, indicated by the mark “[***],” were omitted and have been filed separately with the Securities and Exchange Commission pursuant to the Registrant’s application requesting confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

Page 26 of 28

 

	
 
	
Annex 4
	
– Pre-Payment and Security Interest

 

APre-Payment

 

	
1.
	
 Remitting of the Pre-Payment and any Pre-Payment Tranches by BASF is conditioned upon ASPEN granting the security interests as described in this Annex 4. Any Pre-Payment will be paid by BASF to Aspen to the following bank account Aspen Aerogels, Inc.; [***].

 

	
2.
	
After January 1, 2019, ASPEN will credit up to twenty five and three tenths percent (25.3%) of any amounts invoiced by ASPEN for Product sold and delivered to BASF pursuant to this Agreement against the available Pre-Payment Balance, if any.

 

	
3.
	
Pursuant to §5.2,  the Pre-Payment Balance associated with a specific Pre-Payment Tranche, if any, remaining after the applicable Target Date will be repaid by ASPEN by wire transfer to BASF to the following bank account: [***].

 

	
4.
	
The Pre-Payment Balance may be repaid by ASPEN to BASF at any time in whole or in part and for any reason. 

 

BPre-Payment Tranche 1

 

	
1.
	
BASF will remit to ASPEN by wire transfer five million U.S. dollars ($5,000,000) in two installments of two million and five hundred thousand U.S. dollars ($2,500,000) each on or before (i) the later of February 28, 2018 or 5 business days after the security interests as described in this Annex 4 are made effective and (ii) July 1, 2018, respectively. 

 

	
2.
	
Target Date with respect to this Pre-Payment Tranche 1 shall be December 31, 2021.

 

	
3.
	
The repayment of Pre-Payment Tranche 1 according to Annex 4, A 2. is limited to an amount of U.S. dollars $1,670,000 USD (one million six hundred and seventy thousand US dollars) in any given calendar year.

 

	
4.
	
As specified in Annex 2, Total Volume Range in an amount not to exceed [***] of Products in any calendar year during the term of the Agreement.

 

CAdditional Pre-Payment Tranches

 

	
1.
	
Upon ASPEN’s written request, BASF in its sole discretion may offer and Parties may agree to one or more additional Pre-Payment Tranche(s) to be paid by BASF to Aspen by amendment to this Annex 4.

 

	
2.
	
The terms of each such additional Pre-Payment Tranche, if any, will specify pre-payment amounts, remittance dates, Target Dates, interest (if any) and revisions to Total Volume Range, if any. Such terms shall be agreed in writing and signed by both Parties.

 

DSecurity Interest

 

Portions of this Exhibit, indicated by the mark “[***],” were omitted and have been filed separately with the Securities and Exchange Commission pursuant to the Registrant’s application requesting confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

Page 27 of 28

 

ASPEN and BASF will enter into a collateral agreement to secure ASPEN’s obligation to repay the Pre-Payment Balance associated with a specific Pre-Payment Tranche, if any, by the applicable Target Date with the following elements:

 

	
1.
	
With respect to ASPEN’s manufacturing facility located at 3 Dexter Road, East Providence, Rhode Island USA (the “Rhode Island Plant”):

	
 
	
a.
	
A first priority mortgage in all of the real estate owned by ASPEN which constitutes the Rhode Island Plant; and

	
 
	
b.
	
A first priority security interest in all of the machinery and equipment owned by ASPEN which is located at the Rhode Island Plant, subject only to a subordinate security interest in favor of ASPEN’s bank and other lenders.

 

	
2.
	
With respect to intellectual property:

ASPEN will grant to its respective Rhode Island subsidiary nonexclusive licenses under ASPEN’s patents  as necessary in order to operate the machinery and equipment that is the subject of BASF’s security interest while such machinery and equipment is located at the Rhode Island Plant.  Such licenses will be assignable only to a future acquirer of the machinery and equipment at the Rhode Island Plant, and will terminate on any removal of the machinery and equipment from the Rhode Island Plant. 

 

Following any repayment in full of the Pre-Payment, whether in the form of credits against the purchase price of Products, lump sum payments or otherwise, ASPEN’s obligation to maintain the security interest will terminate, and BASF will execute any and all documents reasonably requested by ASPEN releasing all or any part of the security from any lien or encumbrance in favor of BASF.

 

 

Portions of this Exhibit, indicated by the mark “[***],” were omitted and have been filed separately with the Securities and Exchange Commission pursuant to the Registrant’s application requesting confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

Page 28 of 28aspn-ex103_299.htm

 

Exhibit 10.3

Confidential and Proprietary Information of Aspen Aerogels

 

 

Amended and Restated Side Agreement between

BASF Polyurethanes GmbH and Aspen Aerogels, Inc.

 

 

This amended and restated Side Agreement (“Side Agreement”) is made the latest date set forth below (the “Effective Date”) by BASF Polyurethanes GmbH, Elastogranstraße 60, 49443 Lemförde, Germany (“BASF”) and Aspen Aerogels, Inc., 30 Forbes Road, Building B, Northborough, MA 01532, United States of America (“ASPEN”). BASF and ASPEN are each individually referred to as a “Party” and collectively as the “Parties”.

 

The Parties have entered into an amended and restated Supply Agreement (the “Supply Agreement”) dated as of the Effective Date providing, inter alia, for the supply by ASPEN of certain products to BASF. This Side Agreement is the Side Agreement referred to in the Supply Agreement establishing the pricing of Products sold under the Supply Agreement. 

 

Capitalized terms used herein and not otherwise defined have the meanings as defined in the Supply Agreement.

 

1.Calculation of Price. The Price of Product sold by ASPEN and purchased by BASF or its Affiliates under the Supply Agreement for calendar year [***] will be set to [***] per square foot. The price for each successive calendar year will be determined on or before [***] of the previous calendar year by reference to the following cost-plus formula:

 

Price = [***] Cost [***]

 

[***] Cost for the calendar year [***] will be set at [***] per square foot. [***] Cost for each successive calendar year will be determined on or before [***] of the previous calendar year by ASPEN in good faith and consistent with past practice (adjusted if necessary to reflect [***]). Such [***] Cost will include [***]. 

 

[***] for calendar year [***] will be [***]. [***] for each successive calendar year will be calculated by adding [***] of [***] Cost, or subtracting [***] of [***] Cost, [***], to the then [***]. However, in no case shall [***] be less than [***]

 

Notwithstanding the foregoing, [***]. However, under no circumstance is Aspen obliged to reveal to BASF directly or BASF entitled to request from Aspen any details about the customers [***]. Section 4.3 of the Supply Agreement shall apply to ASPEN records related to [***]. 

 

2.Calculation of [***] Cost. [***] Cost [***] will be the sum of [***] and [***]. For any period, [***] will be determined by ASPEN in good faith and consistent with past practice (adjusted if necessary to reflect [***]). [***] developed by Aspen will be subject to BASF audit rights as set forth in Section 4.3 of the Agreement.  

 

For purposes of the calculation of [***] Cost: 

 

[***] is [***] based on standard product formulation. [***] will include, without limitation, [***] that are required to manufacture Products that meet the Specifications.

Portions of this Exhibit, indicated by the mark “[***],” were omitted and have been filed separately with the Securities and Exchange Commission pursuant to the Registrant’s application requesting confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

 

 

[***] is the [***], to convert the raw materials into saleable Products that meet Specifications. [***] will [***].  [***] will include the [***] included in [***] by Aspen consistent with past practice and in accordance with U.S. GAAP.  

 

Normalized Full Capacity is the projected sustainable annual output of Products in the normal course of operations for Aspen’s manufacturing assets in service at any point in time.

 

3.Successor Products. The Price of Successor Products (if any) shall be determined at the time the Parties agree to include the supply of such Successor Products under the terms of the Supply Agreement. No product will be deemed a Successor Product unless and until the Parties have agreed on the Price of such Successor Products.

 

4.Confidential Information. The terms of this Side Agreement will be deemed Confidential Information of ASPEN for purposes of Section 10 of the Supply Agreement.

 

[signature page follows]

 

Agreed and accepted.

ASPEN AEROGELS, INC.      BASF POLYURETHANES GMBH

 

/s/ John F. Fairbanks [***] [***] 

Name: John F. FairbanksName: [***]Name: [***]

Title: Chief Financial OfficerTitle: [***]Title: [***]

Date: February 16, 2018Date: 02-16-2018 Date: 02-16-2018

 

77393948v.1

 
 
Portions of this Exhibit, indicated by the mark “[***],” were omitted and have been filed separately with the Securities and Exchange Commission pursuant to the Registrant’s application requesting confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00282-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00282-of-00352.parquet"}]]